Last updated: April 22, 2026

Application No. 18/870,596

Untitled Application

Unknown

Filed

1600

Priority

Jun 01, 2022 — provisional 63/347,826 +1 more

Examiner

BRANDSEN, BENJAMIN MICHAEL

Art Unit

1693

Tech Center

LUNELLA BIOTECH, INC.

Assignee

Lunella Biotech Inc.

OA Round

1 (Non-Final)

This examiner grants 60% of cases after interview

— +26.9% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 96 resolved cases, 2023–2026

Examiner Intelligence

BRANDSEN, BENJAMIN MICHAEL View full profile →

Grants 60% of resolved cases

Career Allowance Rate

58 granted / 96 resolved

At TC average

Strong +27% interview lift

Without

With

+26.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

45 currently pending

Career history

141

Total Applications

across all art units

Statute-Specific Performance

§101

3.4%

-36.6% vs TC avg

§103

34.5%

-5.5% vs TC avg

§102

20.8%

-19.2% vs TC avg

§112

24.4%

-15.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 96 resolved cases

Prosecution Timeline

1600

Application Filed

Feb 18, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/427,039

Patent 12594275

IMMUNOPHILIN BINDING AGENTS AND USES THEREOF

4y 8m to grant Granted Apr 07, 2026

17/915,121

Patent 12595236

PYRIMIDINE-2,4-DIAMINE COMPOUND AND PREPAREATION METHOD AND APPLICATION THEREOF

3y 6m to grant Granted Apr 07, 2026

18/020,221

Patent 12589162

Trans-Cyclooctene Prodrug of Monomethyl Auristatin E

3y 1m to grant Granted Mar 31, 2026

17/618,729

Patent 12570610

MACROMOLECULE-SUPPORTED AMINOBENZAZEPINE COMPOUNDS

4y 2m to grant Granted Mar 10, 2026

18/957,502

Patent 12558356

IMMUNOPHILIN BINDING AGENTS AND USES THEREOF

1y 3m to grant Granted Feb 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

60%

Grant Probability

87%

With Interview (+26.9%)

3y 4m

Median Time to Grant

Low

PTA Risk

Based on 96 resolved cases by this examiner. Grant probability derived from career allowance rate.